Thymosin β4 has tumor suppressive effects and its decreased expression results in poor prognosis and decreased survival in multiple myeloma.
about
Thymosin β10 expression driven by the human TERT promoter induces ovarian cancer-specific apoptosis through ROS productionComparative study of joint analysis of microarray gene expression data in survival prediction and risk assessment of breast cancer patients.Shear force-based genetic screen reveals negative regulators of cell adhesion and protrusive activity.miRNAs in multiple myeloma--a survival relevant complex regulator of gene expressionThymosin-β4 is a determinant of drug sensitivity for Fenretinide and Vorinostat combination therapy in neuroblastoma.Preventive and therapeutic effects of thymosin β4 N-terminal fragment Ac-SDKP in the bleomycin model of pulmonary fibrosis.
P2860
Thymosin β4 has tumor suppressive effects and its decreased expression results in poor prognosis and decreased survival in multiple myeloma.
description
2009 nî lūn-bûn
@nan
2009 թուականի Հոկտեմբերին հրատարակուած գիտական յօդուած
@hyw
2009 թվականի հոտեմբերին հրատարակված գիտական հոդված
@hy
2009年の論文
@ja
2009年論文
@yue
2009年論文
@zh-hant
2009年論文
@zh-hk
2009年論文
@zh-mo
2009年論文
@zh-tw
2009年论文
@wuu
name
Thymosin β4 has tumor suppress ...... survival in multiple myeloma.
@ast
Thymosin β4 has tumor suppress ...... survival in multiple myeloma.
@en
Thymosin β4 has tumor suppress ...... survival in multiple myeloma.
@nl
type
label
Thymosin β4 has tumor suppress ...... survival in multiple myeloma.
@ast
Thymosin β4 has tumor suppress ...... survival in multiple myeloma.
@en
Thymosin β4 has tumor suppress ...... survival in multiple myeloma.
@nl
prefLabel
Thymosin β4 has tumor suppress ...... survival in multiple myeloma.
@ast
Thymosin β4 has tumor suppress ...... survival in multiple myeloma.
@en
Thymosin β4 has tumor suppress ...... survival in multiple myeloma.
@nl
P2093
P2860
P50
P1433
P1476
Thymosin β4 has tumor suppress ...... survival in multiple myeloma.
@en
P2093
Ben Van Camp
Bernard Klein
Elke De Bruyne
Els Van Valckenborgh
Ine Kuipers
Karin Vanderkerken
Tomas Jan Bos
P2860
P304
P356
10.3324/HAEMATOL.2009.006411
P577
2009-10-14T00:00:00Z